Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 163036, 11 pages
http://dx.doi.org/10.1155/2014/163036
Review Article

Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective

Ming Guo,1,2 Yue Liu,1,2 Zhu-Ye Gao,1,2 and Da-zhuo Shi1,2

1Cardiovascular Diseases Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
2China Heart Institute of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100091, China

Received 1 December 2013; Accepted 6 January 2014; Published 13 February 2014

Academic Editor: Waris Qidwai

Copyright © 2014 Ming Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Y. Hu and J. H. Wang, “The status of chinese prevention and treatment of dyslipidemia,” Chinese Journal of Practical Internal Medicine, vol. 29, no. 1, pp. 2–3, 2009. View at Google Scholar
  2. N. J. Stone, J. Robinson, A. H. Lichtenstein et al., “2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology/American heart association task force on practice guidelines,” Circulation, 2013. View at Publisher · View at Google Scholar
  3. J. M. McKenney, “Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks,” The American Journal of Cardiology, vol. 96, no. 4, pp. 60–66, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. G. Jiang, “The clinical study progress of Chinese herbal medicine for hyperlipidemia,” Journal of Practical Traditional Chinese Medicine, vol. 24, no. 9, pp. 614–615, 2008. View at Google Scholar
  5. H. X. Shi and Q. H. Li, “Research progress of traditional Chinese medicine treatment of hyperlipidemia,” Journal of Medical Forum, vol. 28, no. 10, pp. 123–124, 2007. View at Google Scholar
  6. Z. P. Xu, Z. J. Lu, J. H. Chen, X. Deng, Y. Mao, and X. Huo, “The effect of rhubarb ethanol-extract on hyperlipidemia and liver fatty in rabbits,” Zhongguo Ying Yong Sheng Li Xue Za Zhi, vol. 23, no. 3, pp. 375–380, 2007. View at Google Scholar · View at Scopus
  7. Q. Gao, W. S. Qin, Z. H. Jia et al., “Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy,” Planta Medica, vol. 76, no. 1, pp. 27–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. H. Xiong, “effect of rhubarb on lipid and TGF-β1 level in patients with diabetic nephropathy,” Journal of Hannan Medical University, vol. 18, no. 8, pp. 1066–1068, 2012. View at Google Scholar
  9. R. Zhou, L. Wang, X. Xu et al., “Danthron activates AMP-activated protein kinase and regulates lipid and glucose metabolism in vitro,” Acta Pharmacologica Sinica, vol. 34, no. 8, pp. 1061–1069, 2013. View at Publisher · View at Google Scholar
  10. Y. Li and Y. F. Liu, “research review of adverse effect of Rheum tanguticum,” China Pharmacy, vol. 17, no. 9, pp. 710–712, 2006. View at Google Scholar
  11. T. You, The research on the damage of over dose Rhubarb to hepatocyte [M.S. thesis], Chinese Medical Sciences University, 2005.
  12. J. Du, L. N. Sun, W. W. Xing et al., “Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters,” Phytomedicine, vol. 16, no. 6-7, pp. 652–658, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. W. W. Xing, J. Z. Wu, M. Jia, J. Du, H. Zhang, and L. Qin, “Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits,” Biomedicine and Pharmacotherapy, vol. 63, no. 7, pp. 457–462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. S. Park, Y. C. Lee, J. D. Kim, H. Kim, and C. Kim, “Inhibitory effects of Polygonum cuspidatum water extract (PCWE) and its component rasveratrol on acyl-coenzyme A-cholesterol acyltransferase activity for cholesteryl ester synthesis in HepG2 cells,” Vascular Pharmacology, vol. 40, no. 6, pp. 279–284, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Zhu, X. Luo, and Z. Jin, “Effect of resveratrol on serum and liver lipid profile and antioxidant activity in hyperlipidemia rats,” Asian-Australasian Journal of Animal Sciences, vol. 21, no. 6, pp. 890–895, 2008. View at Google Scholar · View at Scopus
  16. L. P. Tong, “Oral Polygonum cuspidatum decoction to gastrointestinal adverse reaction in one case,” Lishizhen Medicine and Materia Medica Research, vol. 13, no. 5, p. 277, 2002. View at Google Scholar
  17. J. Chen, H. Zhao, Y. Yang, B. Liu, J. Ni, and W. Wang, “Lipid-lowering and antioxidant activities of Jiang-Zhi-Ning in Traditional Chinese Medicine,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 919–930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. H. Lin and Y. Xiong, “Effects of cassia seeds on blood fat of rats with hyperlipemia,” The New Journal of Traditional Chinese Medicine, vol. 42, no. 7111, 112 pages, 2010. View at Google Scholar
  19. H. B. Li, K. Y. Fang, C. T. Lu, and X. Li, “Study on lipid-regulating function for the extracts and their prescriptions from semen cassiae and fructus crataegi,” Zhong Yao Cai, vol. 30, no. 5, pp. 573–575, 2007. View at Google Scholar · View at Scopus
  20. X. Luo, X. Xu, C. Huang et al., “Experiment study of total anthraquinone in cassiae semen on lipid peroxidation and PPAR-γ expression in liver tissues of rats with alcoholic fatty liver,” Zhongguo Zhong Yao Za Zhi, vol. 36, no. 12, pp. 1654–1659, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Y. Zou and J. S. Li, “Analysis of the potential satety risk of semen cassiae-containing health foods,” Food Science and Technology, vol. 34, no. 5, pp. 295–297, 2009. View at Google Scholar
  22. J. Y. Zhou, S. W. Zhou, K. B. Zhang et al., “Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats,” Biological and Pharmaceutical Bulletin, vol. 31, no. 6, pp. 1169–1176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. X. X. Chang, H. M. Yan, Q. Xu et al., “The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet,” Lipids in Health and Disease, vol. 11, article 86, 2012. View at Publisher · View at Google Scholar
  24. Y. Hu, E. A. Ehli, J. Kittelsrud et al., “Lipid-lowering effect of berberine in human subjects and rats,” Phytomedicine, vol. 19, no. 10, pp. 861–867, 2012. View at Publisher · View at Google Scholar
  25. Z. Liu, X. Zhou, P. Su et al., “Experimental study of total flavonoids from stem-leaf of Scutellaria Baicalensis in treating type 2 diabetic hyperlipidemia,” Traditional Chinese Drug Research and Clinical Pharmacology, vol. 20, no. 1, pp. 5–7, 2009. View at Google Scholar
  26. S. Megalli, N. M. Davies, and B. D. Roufogalis, “Anti-hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 9, no. 3, pp. 281–291, 2006. View at Google Scholar · View at Scopus
  27. L. Zhou, Y. P. Xu, Y. Wei, X. P. Shi, and C. P. Liu, “The effect of Gynostemma pentaphyllum (GP) on plasma lipoprotein metabolism and lipoperoxidation lipoprotein in the experimental hyperglycemia rats,” Zhongguo Ying Yong Sheng Li Xue Za Zhi, vol. 24, no. 2, pp. 205–208, 2008. View at Google Scholar
  28. Z. Y. Deng, S. M. Zhu, D. Wang et al., “Effect of Puerarin on lipidemia, blood coagulation and platelet aggregation in hyperlipidemia rats,” Chinese Journal of Modern Applied Pharmacy, vol. 28, no. 7, pp. 611–614, 2011. View at Google Scholar
  29. J. Wang, Y. Guo, J. Niu, J. Liu, L. Wang, and P. Li, “Effects of Radix Puerariae flavones on liver lipid metabolism in ovariectomized rats,” World Journal of Gastroenterology, vol. 10, no. 13, pp. 1967–1970, 2004. View at Google Scholar · View at Scopus
  30. J. P. Xiong, H. W. Guo, and X. F. Gu, “Study on effect of hawthorn fruit extraction on human blood lipids,” Chinese Journal of Public Health, vol. 20, no. 12, pp. 1469–1470, 2004. View at Google Scholar
  31. C. Kwok, C. Li, H. Cheng et al., “Cholesterol lowering and vascular protective effects of ethanolic extract of dried fruit of Crataegus pinnatifida, hawthorn (Shan Zha), in diet-induced hypercholesterolaemic rat model,” Journal of Functional Foods, vol. 5, no. 3, pp. 1326–1335, 2013. View at Publisher · View at Google Scholar
  32. C. Lin, T. Li, and M. Lai, “Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia,” European Journal of Endocrinology, vol. 153, no. 5, pp. 679–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. O. Gheith, H. Sheashaa, M. Abdelsalam, Z. Shoeir, and M. Sobh, “Efficacy and safety of Monascus purpureus Went rice in children and young adults with secondary hyperlipidemia: a preliminary report,” European Journal of Internal Medicine, vol. 20, no. 3, pp. e57–e61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Jiang, J. Qian, S. Chen, W. Zhang, and C. Liu, “Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress,” Pharmaceutical Biology, vol. 49, no. 8, pp. 856–863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. G. F. Wang, C. G. Shi, M. Z. Sun et al., “Tetramethylpyrazine attenuates atherosclerosis development and protects endothelial cells from ox-LDL,” Cardiovascular Drugs and Therapy, vol. 27, no. 3, pp. 199–210, 2013. View at Publisher · View at Google Scholar
  36. W. Ji and B. Q. Gong, “Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats,” Journal of Ethnopharmacology, vol. 119, no. 2, pp. 291–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. Li, Y. P. Li, and H. Huang, “The effects of tanshinone IIA sulfonate on hemorheology and blood lipid in patients with diabetes mellitus,” Journal of Clinical Rational Drug Use, vol. 4, pp. 8–9, 2011. View at Google Scholar
  38. E. Jang, M. Choi, U. J. Jung et al., “Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat—fed hamsters,” Metabolism, vol. 57, no. 11, pp. 1576–1583, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. B. Di, Z. L. Gu, X. D. Zhao et al., “Research on curcumin for the prevention and control of fatty liver in rats,” Chinese Traditional and Herbal Drugs, vol. 19, no. 8, pp. 1322–1326, 2010. View at Google Scholar
  40. H. E. Xiong-Wei, “The clinical control study on the effect of rhizoma alismatis on blood fat in health volunteers,” Journal of Chongqing Medical University, vol. 34, no. 3, pp. 376–378, 2009. View at Google Scholar
  41. S. Z. Li, Z. J. Jin, and S. Y. Zhang, “The effects of alisma orientalis's extracts on blood lipid and antioxidation of experimental hyperlipidemia mice,” China Practical Medicine, vol. 332, pp. 7–9, 2008. View at Google Scholar
  42. Y. P. Zhao, L. Lu, Y. F. Zhang et al., “Study on discriminating nephrotoxic components in zexie,” China Journal of Chinese Materia Medica, vol. 36, no. 6, pp. 758–761, 2011. View at Google Scholar
  43. S. M. Wang, G. L. Yang, H. Y. Dai et al., “Effect of plantain seed on the lipid peroxidation in rats with hyperlipidemia,” Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu, vol. 10, no. 19, pp. 184–186, 2006. View at Google Scholar
  44. A. L. Romero, K. L. West, T. Zern, and M. L. Fernandez, “The seeds from Plantago ovata lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs,” Journal of Nutrition, vol. 132, no. 6, pp. 1194–1198, 2002. View at Google Scholar · View at Scopus
  45. H. Du, J. You, X. Zhao, J. Park, S. Kim, and K. Chang, “Antiobesity and hypolipidemic effects of lotus leaf hot water extract with taurine supplementation in rats fed a high fat diet,” Journal of Biomedical Science, vol. 17, supplement 1, article S42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Zhou, D. Luo, X. Li, and Y. Luo, “Hypoglycemic and hypolipidemic effects of flavonoids from lotus (Nelumbo nuficera Gaertn) leaf in diabetic mice,” Journal of Medicinal Plant Research, vol. 3, no. 4, pp. 290–293, 2009. View at Google Scholar · View at Scopus
  47. C. Wu, M. Yang, K. Chan, P. Chung, T. Ou, and C. Wang, “Improvement in high-fat diet-induced obesity and body fat accumulation by a nelumbo nucifera leaf flavonoid-rich extract in mice,” Journal of Agricultural and Food Chemistry, vol. 58, no. 11, pp. 7075–7081, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. B. Qiu, J. Liu, and F. Wu, “Research on chemical compositions and pharmacology role of Astragalus,” Chinese Journal of Convalescent Medicine, vol. 20, no. 5, pp. 435–436, 2011. View at Google Scholar
  49. Y. H. Wang, J. G. Qin, W. Q. Guo et al., “Expermiental study of ginsenoside on inhibiting hyperlipemia and atherosclerosis,” Chinese Archives of Traditional Chinese Medicine, vol. 24, no. 3, pp. 429–430, 2006. View at Google Scholar
  50. X. M. Zhang, S. C. Qu, D. Y. Sui, X. Yu, and Z. Lv, “Effects of ginsenoside-Rb on blood lipid metabolism and anti-oxidation in hyperlipidemia rats,” Zhongguo Zhong Yao Za Zhi, vol. 29, no. 11, pp. 1085–1088, 2004. View at Google Scholar · View at Scopus
  51. X. Congkun, W. Rui, and Y. Zhifang, “Study on effect of Polygonum mutiflorum extract on lipid metabolism and its anti-oxidation in SD rats with hyperlipemia,” China Pharmaceuticals, vol. 18, no. 24, pp. 19–20, 2009. View at Google Scholar
  52. C. Wang, L. Zhang, Z. Yuan, Y. Jin, and Z. Zhang, “Blood lipid regulation of ethyl acetate extracting fraction and stilbene glycoside from tuber of Polygonum multiflorum,” Chinese Traditional and Herbal Drugs, vol. 39, no. 1, pp. 78–83, 2008. View at Google Scholar · View at Scopus
  53. H. Dong, Y. Zhao, L. Zhao, and F. Lu, “The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials,” Planta Medica, vol. 79, no. 6, pp. 437–446, 2013. View at Publisher · View at Google Scholar
  54. Z. Y. Lei, “The medical security of Rhizoma coptidis and berberine,” China Pharmaceuticals, vol. 19, no. 9, pp. 84–85, 2010. View at Google Scholar
  55. X. L. Li and L. Tong, “The study progress of chemical components and pharmacological role of Scutellaria baicalensis stem leaf,” Journal of Chengde Medical College, vol. 23, no. 3, pp. 284–286, 2006. View at Google Scholar
  56. B. Regulska-Ilow, J. Biernat, H. Grajeta, R. Ilow, and M. Drzewicka, “Influence of bioflavonoids from the radix extract of Scutellaria baicalensis on the level of serum lipids, and the development of laboratory rats fed with fresh and oxidized fats,” Nahrung, vol. 48, no. 2, pp. 123–128, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. C. L. You, P. Q. Su, and X. X. Zhou, “Study on effect and mechanism of Scutellaria baicalensis stem-leaf total flavonoid in regulating lipid metabolism,” Zhongguo Zhong Yao Za Zhi, vol. 33, no. 9, pp. 1064–1066, 2008. View at Google Scholar · View at Scopus
  58. X. L. Pu and Q. Wu, “Progressive study on Gynostemma pentaphyllum,” Lishizhen Medicine and Materia Medica Research, vol. 21, no. 7, pp. 1758–1760, 2010. View at Google Scholar
  59. S. Megalli, F. Aktan, N. M. Davies, and B. D. Roufogalis, “Phytopreventive anti-hyperlipidemic effects of Gynostemma pentaphyllum in rats,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 3, pp. 507–515, 2005. View at Google Scholar · View at Scopus
  60. C. Müller, A. Gardemann, G. Keilhoff, D. Peter, I. Wiswedel, and L. Schild, “Prevention of free fatty acid-induced lipid accumulation, oxidative stress, and cell death in primary hepatocyte cultures by a Gynostemma pentaphyllum extract,” Phytomedicine, vol. 19, no. 5, pp. 395–401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. D. H. Zhang, Q. B. Dong, and S. G. Peng, “Chemical componets, pharmacologic actions and clinical study of Radix Puerariae,” Captical Medicine, no. 12, pp. 44–45, 2007. View at Google Scholar
  62. L. P. Yan, S. W. Chan, A. S. Chan, S. Chen, X. Ma, and H. Xu, “Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats,” Life Sciences, vol. 79, no. 4, pp. 324–330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. W. Xie, Y. Zhao, and L. Du, “Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia,” Journal of Ethnopharmacology, vol. 140, no. 2, pp. 345–367, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Lin, M. A. Vermeer, and E. A. Trautwein, “Triterpenic acids present in hawthorn lower plasma cholesterol by inhibiting intestinal ACAT activity in hamsters,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 801272, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. C. Niu, C. Chen, L. Chen, K. Cheng, C. Yeh, and J. Cheng, “Decrease of blood lipids induced by Shan-Zha (fruit of Crataegus pinnatifida) is mainly related to an increase of PPAR in liver of mice fed high-fat diet,” Hormone and Metabolic Research, vol. 43, no. 9, pp. 625–630, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. Q. Shang, Z. Liu, K. Chen, H. Xu, and J. Liu, “A systematic review of xuezhikang, an extract from red yeast rice, for coronary heart disease complicated by dyslipidemia,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 636547, 18 pages, 2012. View at Publisher · View at Google Scholar
  67. H. P. M. Kumari, K. A. Naidu, S. Vishwanatha, K. Narasimhamurthy, and G. Vijayalakshmi, “Safety evaluation of Monascus purpureus red mould rice in albino rats,” Food and Chemical Toxicology, vol. 47, no. 8, pp. 1739–1746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. B. Shu, C. J. Zhou, Y. H. Ma, Y. Wang, and Q. Shi, “Research progress on pharmacological activities of the available compositions in Chinese medicinal herb Ligusticum chuanxiong,” Chinese Pharmacological Bulletin, vol. 22, no. 9, pp. 1043–1047, 2006. View at Google Scholar · View at Scopus
  69. L. Y. Xia, Modern Toxicology of Chinese Materia Medica, Tianjin Science and Technology Translation & Publishing Corporation, 2005.
  70. A. L. Liu, M. Y. Lee, and Y. T. Wang, “Research progress on active principles from Salvia miltiorrhizae,” Chinese Pharmaceutical Journal, vol. 42, no. 9, pp. 641–646, 2007. View at Google Scholar · View at Scopus
  71. Y. Kang, U. Jin, H. Chang et al., “Inhibition of microsomal triglyceride transfer protein expression and atherogenic risk factor apolipoprotein B100 secretion by tanshinone IIA in HepG2 cells,” Phytotherapy Research, vol. 22, no. 12, pp. 1640–1645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. J. R. Li and D. H. Zheng, “Research study on pharmacologic action and advese effect of Salvia miltiorrhiza,” Chinese Journal of Ethnomedicine and Ethnopharmacy, vol. 19, no. 24, p. 31, 2010. View at Google Scholar
  73. C. Y. Liu, “Chemical constituents of Curcuma longa L.,” Shenyang Pharmaceutical University, 2008.
  74. M. M. Mahfouz, Q. Zhou, and A. F. Kummerow, “Effect of curcumin on LDL oxidation in vitro, and lipid peroxidation and antioxidant enzymes in cholesterol fed rabbits,” International Journal for Vitamin and Nutrition Research, vol. 81, no. 6, pp. 378–391, 2011. View at Publisher · View at Google Scholar
  75. X. B. Dou, X. D. Wo, C. L. Fan et al., “Effect of curcumin on the expression of low density lipoprotein receptor in HepG2 cell line,” Chinese Pharmaceutical Journal, vol. 42, no. 8, pp. 572–575, 2007. View at Google Scholar · View at Scopus
  76. C. W. Li and S. S. Wu, “The research progress of rhizoma alismatis on regulating blood lipids,” Asia-Pacific Traditional Medicine, vol. 5, no. 10, pp. 152–153, 2009. View at Google Scholar
  77. C. Xiong, N. Wang, S. M. Wang et al., “The study on the general pharmacology of polysaccharides from semen plantaginis,” Journal of Bethune Military Medical College, vol. 6, no. 4, pp. 196–198, 2008. View at Google Scholar
  78. R. Solà, E. Bruckert, R. Valls et al., “Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: A randomised trial,” Atherosclerosis, vol. 211, no. 2, pp. 630–637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. F. G. Wang, J. Cao, B. Liu et al., “The chemical composition of lotus leaf and its pharmacological action research progress,” Lishizhen Medicine and Materia Medica Research, vol. 21, no. 9, pp. 2339–2340, 2010. View at Google Scholar
  80. M. Jiangwei, Q. Zengyong, and X. Xia, “Aqueous extract of Astragalus mongholicus ameliorates high cholesterol diet induced oxidative injury in experimental rats models,” Journal of Medicinal Plant Research, vol. 5, no. 5, pp. 855–858, 2011. View at Google Scholar · View at Scopus
  81. X. Yang, L. P. Jiang, and S. Wang, “Effect of polysaccharides from Astragalus on blood lipid, immune function and oxidative stress in hyperlipidemic rats,” Research and Practice on Chinese Medicines, vol. 26, no. 5, pp. 37–40, 2012. View at Google Scholar
  82. Y. J. Cheng, “The regulation of Astragalus polysaccharide on plasma cholesterol and its mechanism in hyperlipidemia rats,” Sun Yat-sen University, 2010.
  83. Y. Wang, L. P. Guo, H. C. Shang et al., “Literature analysis on 560 cases of adverse drug reactions/events of Astragalus injection,” Journal of Traditional Chinese Medicine, vol. 52, no. 9, pp. 37–40, 2011. View at Google Scholar
  84. Y. Li, T. J. Zhang, S. X. Liu et al., “Research on chemical compositions and pharmacology role of Gingeng,” Chinese Traditional and Herbal Drugs, vol. 40, no. 1, pp. 164–166, 2009. View at Google Scholar
  85. L. P. Christensen, “Chapter 1 ginsenosides: chemistry, biosynthesis, analysis, and potential health effects,” Advances in Food and Nutrition Research, vol. 55, pp. 1–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. D. Y. Kim, H. D. Yuan, I. K. Chung, and S. H. Chung, “Compound k, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK Activation in human hepatoma cells,” Journal of Agricultural and Food Chemistry, vol. 57, no. 4, pp. 1532–1537, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. X. S. Zhang and Q. L. Liu, “The reasearch progress of hypolipidemic and anti-atherosclerosis roles of Polygonum multiflorum,” International Medicine and Health Guidance News, vol. 13, no. 16, pp. 155–157, 2007. View at Google Scholar
  88. X. Han, C. A. Wu, W. Wang et al., “mechanism research of stibene glucoside from Polygonum multiflorum,” Chinese Archives of Traditional Chinese Medicine, vol. 26, no. 8, pp. 1687–1689, 2008. View at Google Scholar
  89. N. Li, Z. Chen, X. Mao, J. Yu, and R. Zhao, “Effects of lipid regulation using raw and processed radix polygoni multiflori in rats fed a high-fat diet,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 329171, 10 pages, 2012. View at Publisher · View at Google Scholar
  90. P. F. Wei, X. Q. Hu, and A. J. Yan, “The adverse response of Polygonum multiflorum,” Shaanxi Journal of Traditional Chinese Medicine, vol. 25, no. 2, pp. 170–171, 2004. View at Google Scholar
  91. S. H. Wang, “The summary on adverse reactions of Polygonum multiflorum,” Journal of Practical Traditional Chinese Medicine, vol. 19, no. 3, p. 163, 2003. View at Google Scholar
  92. Y. Feng, H. Xu, and K. Chen, “Natural polypill Xuezhikang: its clinical benefit and potential multicomponent synergistic mechanisms of action in cardiovascular disease and other chronic conditions,” Journal of Alternative and Complementary Medicine, vol. 18, no. 4, pp. 318–328, 2012. View at Publisher · View at Google Scholar